Oncomed Pharmaceuticals, Inc.

Patents = 94

Forward Citations = 869

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

44 inventors (with patents filed for the assignee):

OncoMed Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibody-based therapeutics to treat cancer. With a focus on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells, OncoMed aims to improve patient outcomes and transform the treatment of cancer. Through strategic collaborations and internal research efforts, the company is advancing multiple investigational candidates, which are evaluated through rigorous clinical trials to deliver innovative cancer therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com